» Authors » Joan R Kanter

Joan R Kanter

Explore the profile of Joan R Kanter including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 5
Citations 185
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Keshwani M, Kanter J, Ma Y, Wilderman A, Darshi M, Insel P, et al.
Proc Natl Acad Sci U S A . 2015 Sep; 112(41):12681-6. PMID: 26417071
Cyclic AMP/protein kinase A (cAMP/PKA) and glucocorticoids promote the death of many cell types, including cells of hematopoietic origin. In wild-type (WT) S49 T-lymphoma cells, signaling by cAMP and glucocorticoids...
2.
Zhang L, Murray F, Rassenti L, Pu M, Kelly C, Kanter J, et al.
Int J Cancer . 2010 Dec; 129(5):1162-9. PMID: 21120911
A cost- and time-efficient means to define the prognosis of patients with chronic lymphocytic leukemia (CLL) is desirable but does not yet exist. On the basis of the evidence that...
3.
Zhang L, Murray F, Zahno A, Kanter J, Chou D, Suda R, et al.
Proc Natl Acad Sci U S A . 2008 Nov; 105(49):19532-7. PMID: 19033455
Cyclic nucleotide phosphodiesterase (PDE) isoforms can influence disease pathogenesis and be novel therapeutic targets. Because lower cAMP levels may contribute to the decreased apoptosis that occurs in chronic lymphocytic leukemia...
4.
Zambon A, Zhang L, Minovitsky S, Kanter J, Prabhakar S, Salomonis N, et al.
Proc Natl Acad Sci U S A . 2005 Jun; 102(24):8561-6. PMID: 15939874
Although a substantial number of hormones and drugs increase cellular cAMP levels, the global impact of cAMP and its major effector mechanism, protein kinase A (PKA), on gene expression is...
5.
Moore M, Kanter J, Jones K, Taylor S
J Biol Chem . 2002 Oct; 277(49):47878-84. PMID: 12372837
The identification of phosphoinositide-dependent kinase-1 (PDK-1) as an activating kinase for members of the AGC family of kinases has led to its implication as the activating kinase for cAMP-dependent protein...